MDSCongress2017 [Vancouver, Canada]

MDSCongress2017 [Vancouver, Canada]

The International Congress of Parkinson’s disease and Movement Disorders Society (MDSCongress2017) was held in the heart of Canada, Vancouver. A four day annual congress which saw a global presence from 89 countries saw an opportunity for collaboration of knowledge. This year was a packed congress with 4300 people expected to attend and high ranking abstracts from around the world being presented. The venue itself was spectacular with a 30 degree forecast and the conference held at the Vancouver Conference Center, overlooking the mountains.

King’s research team did amazing this year, with Professor K Ray Chaudhuri being part of several key talks and sessions. From our team 3 travel grants were awarded, 2 study group abstracts, and 7 abstracts presented overall. Well done team for another great conference and international presence!

Abstracts Presented

Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. A. Qamar, K.R. Chaudhuri

Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort

R. Taddei, A. Sauerbier, M. A. Qamar, K. Ray Chaudhuri

Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients

M. A. Qamar, A. Sauerbier, A. Rizos, K. Ray Chaudhuri

Parkinson’s disease phenotype across different ethnic groups: Comparison of non-motor symptoms in patients living in the United Kingdom and Mexico

A. Sauerbier, M. Rodriguez Violante, A. Cervantes Arriaga, A. Rizos, D. Trivedi, P. Martinez-Martin, M. Parry, M. Rosa-Grilo, R. Brown, K. Ray Chaudhuri

Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann

Double-blind, randomized, placebo-controlled, Phase III study (TOLEDO) to evaluate the efficacy of apomorphine subcutaneous infusion in reducing OFF time in Parkinson’s disease patients with motor fluctuations not well controlled on optimized conventional treatment

R. Katzenschlager, W. Poewe, O. Rascol, C. Trenkwalder, G. Deuschl, K. Ray Chaudhuri, T. Henriksen, T. van Laar, K. Spivey, S. Vel, A. Lees

Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.Ray Chaudhuri

A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease patients

K.Ray Chaudhuri, A. Antonini, W. Poewe, D. Standaert, P. Odin, J. Zamudio, L. Bergmann

Translating the Parkinson´s Disease Sleep Scale (PDSS-2) into 31 Languages Using a Standardized Methodology

K.Ray Chaudhuri, C. Trenkwalder, C. Anfray, M.-P. Emery, C. Acquadro (London, United Kingdom)

Non-motor symptom burden is associated with thalamic atrophy in Parkinson’s disease

F. Niccolini, H. Wilson, B. Giordano, K. Diamantopoulos, G. Pagano, K. Ray Chaudhuri, M. Politis (London, United Kingdom)

Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

C. Rodriguez-Blazquez, R. Balestrino, K. Ray Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin